Neurodex TM

Related by string. * : Neurodex / Tm . TMD . TMs . TMS . tm : FinancialWire tm website . TM EA SPORTS . Contact FinancialWire tm . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . Impart IQ TM . through eReleases TM . ICO mim TM . AMD Opteron TM . Onko Sure TM . Solaris TM . Augment TM . FinancialWire tm . deCODE Glaucoma TM * *

Related by context. Frequent words. (Click for all words.) 66 pseudobulbar affect PBA 64 Neurodex 60 registrational 60 phase IIb clinical 60 Panzem R 60 diabetic neuropathic pain 59 Zelrix 59 liposomal formulation 58 application sNDA 58 tanespimycin 58 anticancer compound 58 alvimopan 58 Traficet EN 58 ponatinib 58 confirmatory Phase III 58 SILENOR TM 57 ICA # 57 Lu AA# 57 tezampanel 57 Vilazodone 56 Genasense R oblimersen 56 BEMA Buprenorphine 56 painful diabetic neuropathy 56 elotuzumab 56 Biologics License Application BLA 56 opioid induced constipation 56 postherpetic neuralgia PHN 56 Cloretazine R VNP#M 56 tasimelteon 56 Pivotal Phase III 56 ATryn ® 56 BLA submission 56 Gabapentin GR 56 dirucotide 56 teduglutide 56 IND submission 56 non alcoholic steatohepatitis 56 Pirfenidone 55 Investigational Device Exemption 55 sodium Injection 55 Azedra 55 IMC A# 55 relapsed refractory multiple myeloma 55 BNC# 55 ALN TTR# 55 Staccato loxapine 55 Omigard 55 Octreotide 55 Zenvia 55 refractory Hodgkin lymphoma 55 Solzira 55 Phase IIa clinical trials 55 squalamine 55 Marqibo 54 KNS # 54 injectable formulation 54 KRN# 54 Amrubicin 54 Veronate 54 ApoB SNALP 54 confirmatory Phase 3 54 clinical endpoints 54 Ofatumumab 54 NUVIGIL 54 Icatibant 54 MGCD# [001] 54 NDA submission 54 Phase III Clinical Trial 54 phase IIa 54 Phase 2a clinical 54 Drug Candidate 53 RSD# 53 NEBIDO 53 Phase IIb clinical 53 Topical Interferon Alpha 2b 53 vilazodone 53 FDA Accepts 53 Diamyd ® 53 Marketing Authorization Application MAA 53 investigational drug 53 hypoparathyroidism 53 eltrombopag 53 Fast Track Designation 53 Marketing Authorization Application 53 Acetavance 53 Hepatitis C HCV 53 registrational trial 53 PROMACTA 53 PREOS 53 L Annamycin 53 MBP# [001] 53 QNEXA 53 OFIRMEV 53 MOZOBIL 53 Phase 1b clinical 53 AeroLEF 52 AA amyloidosis 52 Phase Ib clinical 52 GSK# [001] 52 INCB# [002] 52 Phase IIa trial

Back to home page